Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced stage non-small-cell lung cancer

Faculty Medicine Year: 2018
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Cancer Management and Research DOVE MEDICAL PRESS LTD Volume:
Keywords : Efficacy , safety , crizotinib , patients with anaplastic    
Abstract:
Lung cancer is the leading cause of cancer mortality worldwide, despite advances in management, especially with targeted agents and immunotherapy. Numerous oncogenes have been identified that control the growth of these malignancies. Anaplastic lymphoma kinas (ALK) is a tyrosine kinase that develops distorted functioning as a result of chromosomal rearrangement. Crizotinib, a tyrosine kinase inhibitor (TKI), was approved by the Food and Drug Administration (FDA) in 2011 for the treatment of advanced ALK-positive non-small-cell lung cancer (NSCLC). -In NSCLC, crizotinib is a viable treatment option with good response and tolerable toxicity for patients with ALK-positive advanced disease
    
     
 
       

Author Related Publications

    Department Related Publications

    • Foad Mohamed Mohamed Abotaleb, "تقييم ال بر 53 فى مرضى أورام الغدد الليمفاوية الفيرهوجكين العنيفة المرتجة والمقاومة للعلاج بيرتوكول دى – اتش ايه بى", لايوجد, 1900 More
    • Foad Mohamed Mohamed Abotaleb, "دراسات كهروفسيولوجية وهستوباثولوجية فى اعتلال الاعصاب الطرفية نتيجة عقار خلوى سام (مضاد للاورام", لايوجد, 1900 More
    • Rasha Mohamed Mostafa Hagag, "CD25 عالية FoxP3 لخلايا تي التنظيمية في سرطان الدم الميلودى المزمن النموذجية والغير نموذجية موجبة الفيلادلفيا و علاقتها بالاستجابة للعلاج بالايميتنيب", Journal of American Science Volume 11(5); pages 34-41 2015, 2015 More
    • Shereen Mostafa Saleh Elshorbagy, "- CD200 supresses the Natural Killer Cells and Decreased its Activity in acute Myeloid Leukemia Patients.", . J Leukemia 3: 190, 2015 More
    • Ahmed Abdelrehem Ahmed Abdulrihem, "Can Resection Of Liver Metastasis Improve Survival After Resectability Conversion Chemotherapy In Patients With Metastatic Colo-Rectal Cancer?", International Journal of Advanced Research, 2016 More
    Tweet